Covetrus: Q3 Earnings Insights

Shares of Covetrus CVET were flat in after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share were up 52.94% year over year to $0.26, which beat the estimate of $0.18.

Revenue of $1,126,000,000 up by 10.61% from the same period last year, which beat the estimate of $1,050,000,000.

Looking Ahead

Covetrus hasn't issued any earnings guidance for the time being.

Covetrus hasn't issued any revenue guidance for the time being.

Conference Call Details

Date: Nov 10, 2020

Time: 04:30 PM

ET Webcast URL: https://edge.media-server.com/mmc/p/jmd2epho

Recent Stock Performance

52-week high: $30.13

52-week low: $4.04

Price action over last quarter: Up 15.81%

Company Overview

Covetrus Inc is an animal-health technology and services company dedicated to supporting the companion, equine, and large-animal veterinary markets. Its segments are North America, Europe, and APAC and Emerging Markets. The company's services include supply chain services, software solutions, and prescription management.